Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

For Staff

Communications, branding and engagement

Find out about editing your website profile, get presentation templates,  and more. Here.

SOCIAL MEDIA

Join us on Facebook and Twitter.

intranet

Our new intranet has been launched. You can find relevant information on finance, HR, our working culture, buildings, communications, and latest news and updates.  You can also go here for room bookings, Health & Safety information, etc.

Latest news

New insights into chronic inflammation in rheumatoid arthritis

Kennedy researchers have uncovered new clues about how immune memory exacerbates inflammation in rheumatoid arthritis, which could lead to better ways to control the disease.

‘Single shot’ malaria vaccine delivery system could transform global immunisation

Oxford researchers have developed programmable microcapsules to deliver vaccines in stages, potentially eliminating the need for booster shots and increasing immunisation coverage in hard-to-reach communities.

Dr Chrissy Bolton wins Best Abstract Award at EULAR 2025 Congress

Kennedy DPhil student Chrissy Bolton has been awarded Best Abstract in Basic and Translational Science at the European Alliance of Associations for Rheumatology 2025 (EULAR) conference.

£1.4m awarded to investigate how tumour mechanics affect the immune response to cancer

Professor Marco Fritzsche from the Kennedy Institute of Rheumatology, is co-leading a research project that has been awarded a £1.4 million Programme Foundation Award from Cancer Research UK, to investigate how physical forces within tumours affect the ability of a type of white blood cell to attack and eliminate cancer cells.